Novartis Investigative Site

Lexington, Massachusetts 02421

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Multiple Sclerosis

Studies at this site

• A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod — Completed